Why is Venmax Drugs falling/rising?

As of 09-Sep, Venmax Drugs & Pharmaceuticals Ltd is experiencing a price increase, currently at Rs 25.20, reflecting a rise of 1.2 or 5.0%. Today's price summary indicates that the stock has outperformed its sector by 4.37% and has gained after eight consecutive days of decline. However, it opened with a loss of 5% and traded within a wide range of Rs 2.4, indicating high volatility with an intraday volatility of 5%. The stock's performance over the past week shows a decline of 12.47%, and over the past month, it has fallen by 13.61%. Despite this, the year-to-date return stands at a positive 39.69%. Notably, there has been a decrease in investor participation, with delivery volume falling by 37.57% against the five-day average, which may contribute to the stock's recent fluctuations.
Broader Market Context: In comparison to the benchmark Sensex, which has gained 1.18% over the past week and 1.56% over the past month, Venmax's short-term performance has been significantly weaker, indicating a divergence from broader market trends. While the stock has shown strong year-to-date performance, the recent declines suggest that it is facing challenges that are not present in the broader market. The high volatility and the drop in investor participation may reflect uncertainty among investors, impacting the stock's ability to maintain its upward momentum despite today's positive movement.